Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Delforge

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Prognostic factors and scores in post-transplantation lymphoproliferative disorders after solid organ transplantationDaan Dierickx, Michel Delforge, Gregor Verhoef
Expert Review of Hematology|March 18, 2021
Immunomodulators in newly diagnosed multiple myeloma: current and future conceptsMichel Delforge, Sophie Vlayen, Nicolas Kint
Clinical Lymphoma, Myeloma & Leukemia|June 29, 2016
Treatment With Doxycycline for Severe Bortezomib-Associated BlepharitisMarie-Charlotte Veys, Michel Delforge, Ilse Mombaerts
Acta Clinica Belgica|August 15, 2015
Lymphoproliferative associated type 1 cryoglobulinemiaPieter Jan P Martens, Hugo Daniels, Michel Delforge
American Journal of Hematology|October 6, 2009
Monocytes from patients with myelodysplastic syndromes are more resistant to inhibition by thalidomideStef Meers, Louis Boon, Gregor Verhoef, et al.
Leukemia Research|April 12, 2003
Amifostine does not preferentially stimulate the growth of residual polyclonal progenitor cells in myelodysplastic syndromesMichel Delforge, Vicky Raets, Victor Van Duppen, et al.
Journal of Pain and Symptom Management|September 12, 2003
Pain during bone marrow aspiration: prevalence and preventionPhiline Vanhelleputte, Kristel Nijs, Michel Delforge, et al.
Annals of Hematology|December 29, 2017
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?Xavier Leleu, Francesca Gay, Anne Flament, et al.
European Heart Journal. Case Reports|March 11, 2022
Combined lenalidomide/bortezomib for multiple myeloma complicated by fulminant myocarditis: a rare case report of widely used chemotherapyMatthias Verbesselt, Evelyne Meekers, Peter Vandenberghe, et al.
Leukemia & Lymphoma|February 5, 2013
Patients with myelodysplastic syndrome and two clones with different interstitial deletions of the long arm of chromosome 5Estelle Verburgh, Anne Hagemeijer, Michel Delforge, et al.
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Prognostic factors and scores in post-transplantation lymphoproliferative disorders after solid organ transplantationDaan Dierickx, Michel Delforge, Gregor Verhoef
Expert Review of Hematology|March 18, 2021
Immunomodulators in newly diagnosed multiple myeloma: current and future conceptsMichel Delforge, Sophie Vlayen, Nicolas Kint
Clinical Lymphoma, Myeloma & Leukemia|June 29, 2016
Treatment With Doxycycline for Severe Bortezomib-Associated BlepharitisMarie-Charlotte Veys, Michel Delforge, Ilse Mombaerts
Acta Clinica Belgica|August 15, 2015
Lymphoproliferative associated type 1 cryoglobulinemiaPieter Jan P Martens, Hugo Daniels, Michel Delforge
American Journal of Hematology|October 6, 2009
Monocytes from patients with myelodysplastic syndromes are more resistant to inhibition by thalidomideStef Meers, Louis Boon, Gregor Verhoef, et al.
Leukemia Research|April 12, 2003
Amifostine does not preferentially stimulate the growth of residual polyclonal progenitor cells in myelodysplastic syndromesMichel Delforge, Vicky Raets, Victor Van Duppen, et al.
Journal of Pain and Symptom Management|September 12, 2003
Pain during bone marrow aspiration: prevalence and preventionPhiline Vanhelleputte, Kristel Nijs, Michel Delforge, et al.
Annals of Hematology|December 29, 2017
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?Xavier Leleu, Francesca Gay, Anne Flament, et al.
European Heart Journal. Case Reports|March 11, 2022
Combined lenalidomide/bortezomib for multiple myeloma complicated by fulminant myocarditis: a rare case report of widely used chemotherapyMatthias Verbesselt, Evelyne Meekers, Peter Vandenberghe, et al.
Leukemia & Lymphoma|February 5, 2013
Patients with myelodysplastic syndrome and two clones with different interstitial deletions of the long arm of chromosome 5Estelle Verburgh, Anne Hagemeijer, Michel Delforge, et al.
Pageof 19